Verve Therapeutics, Inc. (VERV)

NASDAQ: VERV · Real-Time Price · USD

4.850

+0.250 (5.43%)

At close: Nov 22, 2024, 4:00 PM

4.840

-0.010 (-0.21%)

After-hours: Nov 22, 2024, 7:57 PM EST

Verve Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	158.71	206.18	115.41	64.33	8.99	2.99
Short-Term Investments	381.21	417.77	439.4	296.11	63.12	15.8
Cash & Short-Term Investments	539.92	623.95	554.81	360.44	72.11	18.78
Cash Growth	11.27%	12.46%	53.92%	399.84%	283.94%	-
Receivables	2.63	5.9	1.01	-	-	-
Prepaid Expenses	13.91	8.1	7.34	6.69	1.85	0.27
Total Current Assets	556.46	637.95	563.16	367.13	73.97	19.05
Property, Plant & Equipment	99.55	107.8	110.66	9.06	3.98	2.36
Other Long-Term Assets	7.9	6.94	5.41	7.93	0.46	0.24
Total Assets	663.91	752.69	679.22	384.12	78.41	21.65
Accounts Payable	4.64	6.64	2.42	7.08	0.04	2.41
Accrued Expenses	21.8	19.68	20.46	12.99	7.19	0.86
Current Portion of Leases	10.37	10.19	11.9	1.96	-	-
Other Current Liabilities	0.12	0.5	0.31	-	0.09	0.29
Total Current Liabilities	42.64	37.01	35.1	22.02	7.32	3.55
Long-Term Debt	-	-	-	-	-	9.57
Long-Term Leases	60.89	64.72	70.01	-	-	-
Long-Term Unearned Revenue	50.73	48.56	20.01	-	-	-
Other Long-Term Liabilities	1.1	2.91	3.17	4.75	9.85	2.6
Total Liabilities	155.36	153.19	128.29	26.77	17.16	15.72
Common Stock	0.09	0.08	0.06	0.05	0	0.02
Additional Paid-In Capital	1,200	1,143	895.8	544.38	2.62	1.25
Retained Earnings	-692.98	-544.31	-344.24	-186.85	-66.54	-20.83
Comprehensive Income & Other	1.14	0.27	-0.69	-0.23	0.01	0.01
Total Common Equity	508.55	599.5	550.93	357.35	-63.91	-19.55
Shareholders' Equity	508.55	599.5	550.93	357.35	61.25	5.93
Total Liabilities & Equity	663.91	752.69	679.22	384.12	78.41	21.65
Total Debt	71.26	74.91	81.92	1.96	-	9.57
Net Cash (Debt)	468.67	549.04	472.89	358.49	72.11	9.21
Net Cash Growth	14.75%	16.10%	31.91%	397.13%	682.89%	-
Net Cash Per Share	5.83	8.56	8.75	13.34	32.05	7.21
Filing Date Shares Outstanding	84.66	83.62	61.83	48.58	2.18	1.28
Total Common Shares Outstanding	84.64	81.97	61.73	48.51	2.18	1.28
Working Capital	513.82	600.94	528.06	345.1	66.65	15.5
Book Value Per Share	6.01	7.31	8.92	7.37	-29.28	-15.31
Tangible Book Value	508.55	599.5	550.93	357.35	-63.91	-19.55
Tangible Book Value Per Share	6.01	7.31	8.92	7.37	-29.28	-15.31
Machinery	34.26	32.17	23.5	9.29	4.52	1.82
Leasehold Improvements	0.78	0.73	0.27	0.27	0.26	0.65

Source: S&P Capital IQ. Standard template. Financial Sources.